These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7913683)

  • 1. Clinical trials versus clinical practice in the secondary prevention of myocardial infarction.
    Agustí A; Arnau JM; Laporte JR
    Eur J Clin Pharmacol; 1994; 46(2):95-9. PubMed ID: 7913683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
    Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
    Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.
    Krumholz HM; Radford MJ; Wang Y; Chen J; Heiat A; Marciniak TA
    JAMA; 1998 Aug; 280(7):623-9. PubMed ID: 9718054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.
    Martínez M; Agustí A; Arnau JM; Vidal X; Laporte JR
    Eur J Clin Pharmacol; 1998 May; 54(3):203-8. PubMed ID: 9681660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction.
    Majumdar SR; Inui TS; Gurwitz JH; Gillman MW; McLaughlin TJ; Soumerai SB
    J Gen Intern Med; 2001 Jun; 16(6):351-9. PubMed ID: 11422631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful implementation of guidelines for encouraging the use of beta blockers in patients after acute myocardial infarction.
    Sarasin FP; Maschiangelo ML; Schaller MD; Héliot C; Mischler S; Gaspoz JM
    Am J Med; 1999 May; 106(5):499-505. PubMed ID: 10335720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital.
    Mitra S; Findley K; Frohnapple D; Mehta JL
    Clin Cardiol; 2002 Jan; 25(1):16-8. PubMed ID: 11808833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in myocardial infarction treatment in subjects aged 35-64 in Southwestern France, 1986-93.
    Marques-Vidal P; Ruidavets JB; Cambou JP; Ferrières J
    Int J Cardiol; 2003 Apr; 88(2-3):239-45. PubMed ID: 12714204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) Investigators.
    Avanzini F; Zuanetti G; Latini R; Colombo F; Santoro E; Maggioni AP; Franzosi MG; Tognoni G
    Eur Heart J; 1997 Sep; 18(9):1447-56. PubMed ID: 9458451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance.
    McCormick D; Gurwitz JH; Savageau J; Yarzebski J; Gore JM; Goldberg RJ
    J Gen Intern Med; 1999 Feb; 14(2):73-81. PubMed ID: 10051777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
    JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes.
    Krumholz HM; Radford MJ; Ellerbeck EF; Hennen J; Meehan TP; Petrillo M; Wang Y; Jencks SF
    Ann Intern Med; 1996 Feb; 124(3):292-8. PubMed ID: 8554223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention of coronary heart disease in patients after acute myocardial infarction at the Soroka Medical Center.
    Rubowitz AH; Porath A
    Isr J Med Sci; 1992 Dec; 28(12):856-61. PubMed ID: 1363097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia: comparison of real-world data from 2004 to 2005 and 2017 to 2018.
    Lõiveke P; Marandi T; Ainla T; Fischer K; Eha J
    BMC Cardiovasc Disord; 2021 Oct; 21(1):505. PubMed ID: 34670499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.
    Bennett K; Johnson H; Dack P; Shelley E; Feely J
    Ir J Med Sci; 2005; 174(3):4-8. PubMed ID: 16285330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
    Lamas GA; Pfeffer MA; Hamm P; Wertheimer J; Rouleau JL; Braunwald E
    N Engl J Med; 1992 Jul; 327(4):241-7. PubMed ID: 1535419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.